staurosporine has been researched along with inno-406 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Balistreri, G; Cattelani, L; Cerullo, V; Del Giudice, G; Federico, A; Fratello, M; Greco, D; Horvath, P; Kinaret, PAS; Kuivanen, S; Lieto, AD; Ojha, R; Pavel, A; Provenzani, R; Saarimäki, LA; Serra, A; Tasnadi, E; Vapalahti, O; Yli-Kauhaluoma, J | 1 |
1 other study(ies) available for staurosporine and inno-406
Article | Year |
---|---|
Computationally prioritized drugs inhibit SARS-CoV-2 infection and syncytia formation.
Topics: A549 Cells; Antiviral Agents; Computational Biology; COVID-19; COVID-19 Drug Treatment; Drug Evaluation, Preclinical; Drug Repositioning; Giant Cells; Humans; Pyrimidines; SARS-CoV-2; Staurosporine | 2022 |